https://www.selleckchem.com/pr....oducts/itacnosertib.
With more effective screening and treatment strategies, there is debate over whether surgical axillary staging should be deescalated for patients with small favorable breast cancers, such as tubular carcinoma (TC). We identified patients with TC [defined as 90% tubular tubules (angulated, not multilayered)] and known surgical axillary staging from our institutional database (2000-2018). Using the National Cancer Database (NCD (2004-2015), we identified patients with TC, ductal carcinoma in situ (DCIS), and pT1 estrogen recep
Gefällt mir
Kommentar
Teilen
